Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Use of Antiemetic Agents in Acute Gastroenteritis 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
See Latest ArticlesNew treatment options for fibromyalgia: critical appraisal of duloxetine
Neuropsychiatric Disease and Treatment, 05/13/08
Uceyler N et al. - So far two randomized, placebo-controlled trials have investigated the short-term safety and efficacy of duloxetine 60 mg/day and 120 mg/day in patients suffering from FMS over a period of 12 weeks. Both dosages were superior to placebo in pain relief, and improvement in quality of life and depressive symptoms. The analgesic effect was largely independent of the antidepressant action of duloxetine. The higher dose of 120 mg/day further reduced the tender point count and elevated the tender point pain thresholds. Only mild to moderate adverse effects were reported. Duloxetine 60 mg/day and 120 mg/day has proven to be beneficial in the treatment of FMS symptoms.
Related Articles
Changes in Hippocampal Metabolites After Effective Treatment for Fibromyalgia: A Case Study
The Clinical Journal of Pain, 10/20/09
Relevance Score: 94%
Womens narratives on experiences of work ability and functioning in fibromyalgia
Musculoskeletal Care, 10/23/09
Relevance Score: 93%
General symptom reporting in female fibromyalgia patients and referents: a population-based case-referent study
BMC Public Health, 11/04/09
Relevance Score: 90%
Fibromyalgia: From treatment to rehabilitation
European Journal of Pain, 11/17/09
Relevance Score: 89%
Are chronic fatigue syndrome and fibromyalgia the same? Implications for the provision of appropriate mental health intervention
Journal of Psychiatric and Mental Health Nursing, 11/16/09
Relevance Score: 89%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Taking the stress out of managing gout
Canadian Family Physician, 12/16/09
Responses to Continuous Glucose Monitoring in Subjects with Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion or Multiple Daily Injections
Diabetes Technology & Therapeutics, 12/16/09
Immunosuppression Using the Mammalian Target of Rapamycin (mTOR) Inhibitor Everolimus: Pilot Study Shows Significant Cognitive and Affective Improvement
Transplantation Proceedings, 12/16/09
Today in Mental Health...keeping you current
Receive free subspecialty "5-minute updates" via email
Genetics: Schizophrenia
Canadian Family Physician, 12/16/09
Cannabis and suicide: longitudinal study
British Journal of Psychiatry, 12/16/09
Household Exposure to Secondhand Smoke is Associated with Decreased Physical and Mental Health of Mothers in the USA
Maternal and Child Health Journal , 12/16/09
Today in Ortho/Rheum...keeping you current
Receive free subspecialty "5-minute updates" via email
Taking the stress out of managing gout
Canadian Family Physician, 12/16/09
Early diagnostic procedures in primary care and hospital for children with a painful hip. A prospective study
The European Journal of General Practice, 12/16/09
Motor ability in children treated for idiopathic clubfoot. A controlled pilot study
BMC Pediatrics, 12/16/09
Sponsor
Article Search
Sponsor
Sponsor